CLINICAL_TRIALS
trial_result
· 2008-04-07
Clinical Trial Update: Pegvisomant And Sandostatin LAR Combination Study [Phase 4]
Summary
Phase 4 study evaluating pegvisomant in combination with Sandostatin LAR for acromegaly has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Acromegaly | Phase 4 | Status: COMPLETED